tiprankstipranks
Trending News
More News >
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market

Summit Therapeutics (SMMT) Similar Stocks

Compare
1,834 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Summit Therapeutics
$17.04
$12.66B
-13.72
-7.39%
8 Buy
3 Hold
1 Sell
Moderate Buy
Incyte
$97.31
$19.17B
16.32
45.11%
9 Buy
8 Hold
1 Sell
Moderate Buy
United Therapeutics
$507.00
$22.00B
19.22
40.77%
6 Buy
3 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$199.80
$12.39B
-47.04
45.06%
15 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$31.50
$19.52B
13.27
56.79%
5 Buy
2 Hold
0 Sell
Moderate Buy
BioNTech SE
$91.46
$22.03B
-34.76
-17.86%
12 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SMMT
Summit Therapeutics
17.04
-1.36
-7.39%
INCY
Incyte
97.31
30.25
45.11%
UTHR
United Therapeutics
507.00
146.84
40.77%
ASND
Ascendis Pharma
199.80
62.06
45.06%
GMAB
Genmab
31.50
11.41
56.79%
BNTX
BioNTech SE
91.46
-19.88
-17.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts